483 related articles for article (PubMed ID: 4213330)
61. Post-exposure immunization by capsid-modified AdC7 vector expressing Pseudomonas aeruginosa OprF clears P. aeruginosa respiratory infection.
Gomi R; Sharma A; Wu W; Sung B; Worgall S
Vaccine; 2017 Dec; 35(51):7174-7180. PubMed ID: 29126807
[TBL] [Abstract][Full Text] [Related]
62. Immuno-modulatory functions of the type-3 secretion system and impacts on the pulmonary host defense: A role for ExoS of Pseudomonas aeruginosa in cystic fibrosis.
Belmadi N; Wu Y; Touqui L
Toxicon; 2018 Mar; 143():68-73. PubMed ID: 29339019
[TBL] [Abstract][Full Text] [Related]
63. IgG antibodies in early Pseudomonas aeruginosa infection in cystic fibrosis.
Cordon SM; Elborn JS; Rayner RJ; Hiller EJ; Shale DJ
Arch Dis Child; 1992 Jun; 67(6):737-40. PubMed ID: 1626995
[TBL] [Abstract][Full Text] [Related]
64. Significance of immunologic factors in cystic fibrosis.
Przyklenk B; Bauernfeind A
Scand J Gastroenterol Suppl; 1988; 143():103-9. PubMed ID: 2455329
[TBL] [Abstract][Full Text] [Related]
65. The immunoevasive activities of Pseudomonas aeruginosa. Relevance for cystic fibrosis.
Buret A; Cripps AW
Am Rev Respir Dis; 1993 Sep; 148(3):793-805. PubMed ID: 8368651
[No Abstract] [Full Text] [Related]
66. Serum IgA antibodies against Pseudomonas aeruginosa in cystic fibrosis.
Brett MM; Ghoneim AT; Littlewood JM
Arch Dis Child; 1990 Mar; 65(3):259-63. PubMed ID: 2110441
[TBL] [Abstract][Full Text] [Related]
67. Anti-PcrV titers in non-cystic fibrosis patients with Pseudomonas aeruginosa respiratory tract infection.
Nagaoka K; Yamashita Y; Kimura H; Kimura H; Suzuki M; Fukumoto T; Hayasaka K; Yoshida M; Hara T; Maki H; Ohkawa T; Konno S
Int J Infect Dis; 2019 Oct; 87():54-59. PubMed ID: 31419482
[TBL] [Abstract][Full Text] [Related]
68. Clinical evaluation of Pseudomonas hyperimmune globulin and plasma.
Jones CE; Alexander JW; Fisher MW
Surg Forum; 1970; 21():238-40. PubMed ID: 4105882
[No Abstract] [Full Text] [Related]
69. Epidemiological markers for Pseudomonas aeruginosa. 6. Relationship between concomitant non-mucoid and mucoid strains from the respiratory tract in cystic fibrosis.
Bergan T; Hoiby N
Acta Pathol Microbiol Scand Suppl; 1975 Dec; 83(6):553-60. PubMed ID: 812335
[TBL] [Abstract][Full Text] [Related]
70. Identification and quantitation of precipitins against Pseudomonas aeruginosa in patients with cystic fibrosis by means of crossed immunoelectrophoresis with intermediate gel.
Hoiby N; Axelsen NH
Acta Pathol Microbiol Scand B Microbiol Immunol; 1973 Jun; 81(3):298-308. PubMed ID: 4204843
[No Abstract] [Full Text] [Related]
71. 17β-Estradiol Dysregulates Innate Immune Responses to Pseudomonas aeruginosa Respiratory Infection and Is Modulated by Estrogen Receptor Antagonism.
Abid S; Xie S; Bose M; Shaul PW; Terada LS; Brody SL; Thomas PJ; Katzenellenbogen JA; Kim SH; Greenberg DE; Jain R
Infect Immun; 2017 Oct; 85(10):. PubMed ID: 28784925
[TBL] [Abstract][Full Text] [Related]
72. Analysis of naturally occurring antibodies to mucoid Pseudomonas aeruginosa in cystic fibrosis patients.
Pier GB
J Infect Dis; 1996 Feb; 173(2):513-5. PubMed ID: 8568328
[No Abstract] [Full Text] [Related]
73. Pathogenic mechanisms of chronic Pseudomonas aeruginosa infections in cystic fibrosis patients.
Høiby N; Döring G; Schiøtz PO
Antibiot Chemother (1971); 1987; 39():60-76. PubMed ID: 3118792
[No Abstract] [Full Text] [Related]
74. Phagocytic and signaling innate immune receptors: are they dysregulated in cystic fibrosis in the fight against Pseudomonas aeruginosa?
Sallenave JM
Int J Biochem Cell Biol; 2014 Jul; 52():103-7. PubMed ID: 24508137
[TBL] [Abstract][Full Text] [Related]
75. Understanding
Sainz-Mejías M; Jurado-Martín I; McClean S
Cells; 2020 Dec; 9(12):. PubMed ID: 33291484
[No Abstract] [Full Text] [Related]
76. Association with phagocytic inhibition of anti-Pseudomonas aeruginosa immunoglobulin G antibody subclass levels in serum from patients with cystic fibrosis.
Shryock TR; Mollé JS; Klinger JD; Thomassen MJ
J Clin Microbiol; 1986 Mar; 23(3):513-6. PubMed ID: 3082922
[TBL] [Abstract][Full Text] [Related]
77. Secretory IgA-mediated immune response in saliva and early detection of Pseudomonas aeruginosa in the lower airways of pediatric cystic fibrosis patients.
Mauch RM; Rossi CL; Nolasco da Silva MT; Bianchi Aiello T; Ribeiro JD; Ribeiro AF; Høiby N; Levy CE
Med Microbiol Immunol; 2019 Apr; 208(2):205-213. PubMed ID: 30706137
[TBL] [Abstract][Full Text] [Related]
78. Role of antibody in infections due to Pseudomonas aeruginosa.
Young LS
J Infect Dis; 1974 Nov; 130 Suppl(0):S111-8. PubMed ID: 4213568
[No Abstract] [Full Text] [Related]
79. Bronchial Epithelial Cells from Cystic Fibrosis Patients Express a Specific Long Non-coding RNA Signature upon
Balloy V; Koshy R; Perra L; Corvol H; Chignard M; Guillot L; Scaria V
Front Cell Infect Microbiol; 2017; 7():218. PubMed ID: 28611953
[No Abstract] [Full Text] [Related]
80. Mechanisms of humoral immune response against Pseudomonas aeruginosa biofilm infection in cystic fibrosis.
Mauch RM; Jensen PØ; Moser C; Levy CE; Høiby N
J Cyst Fibros; 2018 Mar; 17(2):143-152. PubMed ID: 29033275
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
